Australia's largest stock trading and investment forum Australia's #1 stock forum

NEA

Click for more information

0.00%

$2.10 nearmap ltd

Ann: Half Year Accounts, page-28

First 28 Last

Share
Profile

Follow
Gillysrooms

10,437 Posts.

142

10/02/16

10:18

Post #: 16983159
Share

Originally posted by Inferno31 ↑

Highlights from teleconference
Recent wins in local municipal governments in US
Change to coverage profile to cover more without the change in cost to match competitor
Increased annual contract value in US from 0.1 mil to 1 mil
Increase in sales and marketing costs due to ongoing expansion in USA
In Australia, product being sold to customers that previously were traditionally not users of imagery systems and new opportunity.
Scaleable business as a result they need only another 10 FTE in US to bring in same revenue as Australia. The FTE will be hired over time.
No need for funding. All expansion will be funded internally and no dilution
If you annualise the results then no increase in expenditure in 2nd half of the year
Hyperpod tech developed and validating output right now - oblique images and 3D models. In process to implement onto platform.
Focus in US is to sell current products. Oblique imagery is a product developed to compete with the large competitor.

They talked about amortisation - did not understand it? Can someone explain that ?

Expand

What's FTE? Amortisation is like depreciation cost.

NEA Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 90 more messages in this thread...

First 28 Last

Add NEA (ASX) to my watchlist